Joel V Chua

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Microorganisms

Tropical medicine and infectious disease

Journal of medical virology

Viruses

Institute of Human Virology, University of Maryland School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Human Virology, University of Maryland School of Medicine Jan 25 2016

United States

Assistant Professor :: Medicine

Publications

Laura Sneller, Christine Lin, Angie Price, Shyamasundaran Kottilil, Joel V Chua
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms 12 (3) (2024)
Hernando Gutierrez-Barbosa, Sandra Medina-Moreno, Federico Perdomo-Celis, Harry Davis, Joel V Chua, Juan Carlos Zapata
Evaluation of Four Humanized NOD-Derived Mouse Models for Dengue Virus-2 Infection. Pathogens (Basel, Switzerland) 13 (8) (2024)
Laura Sneller, Christine Lin, Angie Price, Shyamasundaran Kottilil, Joel V Chua
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms 12 (3) (2024)
Laura Sneller, Christine Lin, Angie Price, Shyamasundaran Kottilil, Joel V Chua
RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects. Microorganisms 12 (3) (2024)
Hernando Gutierrez-Barbosa, Sandra Medina-Moreno, Federico Perdomo-Celis, Harry Davis, Carolina Coronel-Ruiz, Juan C Zapata, Joel V Chua
A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains. Microorganisms 11 (6) (2023)
Hernando Gutierrez-Barbosa, Sandra Medina-Moreno, Federico Perdomo-Celis, Harry Davis, Carolina Coronel-Ruiz, Juan C Zapata, Joel V Chua
A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains. Microorganisms 11 (6) (2023)
Arshi Khanam, Hector Gutiérrez-Barbosa, Kirsten E Lyke, Joel V Chua
Immune-Mediated Pathogenesis in Dengue Virus Infection. Viruses 14 (11) (2022)
Angie S Price, Amy K Nelson, Alip Ghosh, Shyamasundaran Kottilil, Joel V Chua
A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection. Journal of medical virology (2022)
Naomi Hauser, Alexis C Gushiken, Shivakumar Narayanan, Shyam Kottilil, Joel V Chua
Evolution of Nipah Virus Infection: Past, Present, and Future Considerations. Tropical medicine and infectious disease 6 (1) (2021)
Juliet O Obi, Hernando Gutiérrez-Barbosa, Joel V Chua, Daniel J Deredge
Current Trends and Limitations in Dengue Antiviral Research. Tropical medicine and infectious disease 6 (4) (2021)
Arshi Khanam, Joel V Chua, Shyamasundaran Kottilil
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. International journal of molecular sciences 22 (11) (2021)
Hernando Gutierrez-Barbosa, Sandra Medina-Moreno, Juan Carlos Zapata, Joel V Chua
Dengue Infections in Colombia: Epidemiological Trends of a Hyperendemic Country. Tropical medicine and infectious disease 5 (4) (2020)
Joel V Chua, Afua Ntem-Mensah, Ameer Abutaleb, Jennifer Husson, Lydiah Mutumbi, Ka Wing Lam, Alip Ghosh, Sara Romani, Bhawna Poonia, Sam Lee, M Luz Pascual, Lyn R Frumkin, Shyamsundaran Kottilil
Short-duration treatment with the novel non-nucleoside inhibitor CDI-31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open-label study. Journal of medical virology 93 (6) (2020)

Joel V Chua.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joel V Chua